1887

Abstract

Introduction:

We report antigen and antibody responses in a case of multiple invasive fungal diseases.

Case presentation:

The patient, a double‐lung transplant recipient, had candidaemia and invasive pulmonary aspergillosis with cerebral involvement. The follow‐up of the serum galactomannan antigen by ELISA showed a level increase that correlated with the patient’s aggravation. It was retrospectively completed by kinetics analysis using different anti‐ antibody assays (ELISA and Western blotting).

Conclusion:

A balance between the antigen and anti‐ antibodies was shown using different anti‐ antibody assays. The results of these two antibody techniques appeared rather congruent.

Loading

Article metrics loading...

/content/journal/jmmcr/10.1099/jmmcr.0.000026
2015-04-01
2019-12-12
Loading full text...

Full text loading...

/deliver/fulltext/jmmcr/2/2/jmmcr000026.html?itemId=/content/journal/jmmcr/10.1099/jmmcr.0.000026&mimeType=html&fmt=ahah

References

  1. Antinori S., Corbellino M., Meroni L., Resta F., Sollima S., Tonolini M., Tortorano A.M., Milazzo L., Bello L.. other authors.( 2013;). Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect66:218–238[CrossRef]
    [Google Scholar]
  2. Bitar D., Lortholary O., Le Strat Y., Nicolau J., Coignard B., Tattevin P., Che D., Dromer F.. ( 2014;). Population‐based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis20:1163–1169[CrossRef]
    [Google Scholar]
  3. Boutboul F., Alberti C., Leblanc T., Sulahian A., Gluckman E., Derouin F., Ribaud P.. ( 2002;). Invasive aspergillosis in allogeneic stem cell transplant recipients: increasing antigenemia is associated with progressive disease. Clin Infect Dis34:939–943[CrossRef]
    [Google Scholar]
  4. De Pauw B., Walsh T.J., Donnelly J.P., Stevens D.A., Edwards J.E., Calandra T., Pappas P.G., Maertens J., Lortholary O.. other authors.( 2008;). Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis46:1813–1821[CrossRef]
    [Google Scholar]
  5. Herbrecht R., Letscher‐Bru V., Oprea C., Lioure B., Waller J., Campos F., Villard O., Liu K‐L., Natarajan‐Amé S.. other authors.( 2002;). Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol20:1898–1906[CrossRef]
    [Google Scholar]
  6. Kume H., Yamazaki T., Togano T., Abe M., Tanuma H., Kawana S., Okudaira M.. ( 2011;). Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan . Med Mycol J52:117–127[CrossRef]
    [Google Scholar]
  7. Maertens J., Verhaegen J., Lagrou K., Van Eldere J., Boogaerts M.. ( 2001;). Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood97:1604–1610[CrossRef]
    [Google Scholar]
  8. Mennink‐Kersten M.A.S.H., Donnelly J.P., Verweij P.E.. ( 2004;). Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis4:349–357[CrossRef]
    [Google Scholar]
  9. Miceli M.H., Grazziutti M.L., Woods G., Zhao W., Kocoglu M.H., Barlogie B., Anaissie E.. ( 2008;). Strong correlation between serum Aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis46:1412–1422[CrossRef]
    [Google Scholar]
  10. Neofytos D., Fishman J.A., Horn D., Anaissie E., Chang C‐H., Olyaei A., Pfaller M., Steinbach W.J., Webster K.M., Marr K.A.. ( 2010;). Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis12:220–229[CrossRef]
    [Google Scholar]
  11. Park S.H., Choi S‐M., Lee D‐G., Choi J‐H., Kim S‐H., Kwon J‐C., Yoo J‐H., Kim H‐J., Lee S.. other authors.( 2011;). Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients. Mycoses54:523–530[CrossRef]
    [Google Scholar]
  12. Penack O., Rempf P., Graf B., Blau I.W., Thiel E.. ( 2008;). Aspergillus galactomannan testing in patients with long‐term neutropenia: implications for clinical management. Ann Oncol ESMO19:984–989[CrossRef]
    [Google Scholar]
  13. Persat F.. ( 2012;). [Aspergillus serology, from yesterday to today for tomorrow]. J Mycol Med22:72–82 (in French)[CrossRef]
    [Google Scholar]
  14. Piens M.A., Thiébaut A., Bilger K., De Monbrison F., Michallet M., Picot S.. ( 2004;). Intérêt de la détection d’antigène aspergillaire dans le liquide céphalo‐rachidien en cas de suspicion d’aspergillose cérébrale. J Mycol Med14:28–33
    [Google Scholar]
  15. Sendid B., Poirot J.L., Tabouret M., Bonnin A., Caillot D., Camus D., Poulain D.. ( 2002;). Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. J Med Microbiol51:433–442
    [Google Scholar]
  16. Sheppard D.C., Marr K.A., Fredricks D.N., Chiang L.Y., Doedt T., Filler S.G.. ( 2006;). Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin Microbiol Infect12:376–380[CrossRef]
    [Google Scholar]
  17. Verweij P.E.. ( 2009;). Galactomannan and anti‐Aspergillus antibodies detection for the diagnosis of invasive aspergillosis. In Aspergillus fumigatus and Aspergillosis Latgé J P, Steinbach W J. Washington, DC: ASM Press;
    [Google Scholar]
  18. Woods G., Miceli M.H., Grazziutti M.L., Zhao W., Barlogie B., Anaissie E.. ( 2007;). Serum Aspergillus galactomannan antigen values strongly correlate with outcome of invasive aspergillosis: a study of 56 patients with hematologic cancer. Cancer110:830–834[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmmcr/10.1099/jmmcr.0.000026
Loading
/content/journal/jmmcr/10.1099/jmmcr.0.000026
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error